Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04728048
Other study ID # 2021-2334
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 19, 2021
Est. completion date December 2024

Study information

Verified date October 2023
Source Ciusss de L'Est de l'Île de Montréal
Contact Christian Loubert
Phone 5145677340
Email christian.loubert@umontreal.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this prospective randomized controlled study is to compare the number of physician top-up interventions during the first stage of labour between two different neuraxial analgesia techniques : the dural puncture epidural and the standard epidural.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Dural puncture epidural
already described
Standard epidural
already described

Locations

Country Name City State
Canada CIUSSS de l'Est de l'Île de Montréal Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Ciusss de L'Est de l'Île de Montréal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Need for 1 physician epidural top-up The number of parturients who need at least one physician top-up intervention during the first stage of labour. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Number of physician epidural top-ups To compare the number of physician top-up interventions necessary in the first stage of labour between both groups. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Timing of physician top-ups To measure the timing of request for physician top-up interventions and timing of actual physician top-up interventions. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Analgesia scores To evaluate the analgesia, using the verbal numeric pain rating scale (NPRS) from 0 to 10, every 5 minutes after catheter placement until NPRS = 3, and then every hour. Each time, the parturient will evaluate her maximal pain during the last contraction. If the parturient is sleeping and does not wake up in the 30 minutes following the planned analgesia evaluation, we will respect sleep and consider that the analgesia is adequate at that time and will be scored at 0 on the NPRS. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Sacral block To assess the incidence of S2 bilateral blockade every hour, where S2 is assessed at the midpoint of the popliteal fossa. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Asymetrical block To assess the incidence of asymmetrical blockade every hour, which is defined as a difference in sensory blockade to cold sensation greater than 2 dermatomal levels between the left and right sides of the patient. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Motor block To assess the presence of motor blockade every hour, using the Bromage score (1 to 4). Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Ambulation criteria To determine the number of parturients that fulfill ambulation criteria at 30 min, 1 hour and 2 hours after catheter placement. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Ambulation To determine the number of parturients that ambulate at any moment during the first stage of labour. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Urinary catheterisation To determine the number of parturients who need urinary catheterisation for any indication. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Local anesthetic and fentanyl doses To determine the total quantity of local anesthetic (mg) and fentanyl (mcg) that are received during the first stage labour in both groups, including the top-up boluses. Up to 24 hours after inclusion. From installation of epidural analgesia until the end of first stage of labour defined as full cervix dilation or decision by the attending obstetrician to proceed to a cesarean delivery.
Secondary Patient satisfaction To evaluate the parturients overall satisfaction with neuraxial analgesia 24 hours postpartum, using a 0 to 100 scale. A cutoff of = 60 will be taken as poor satisfaction. Up to 48 hours after inclusion.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas